Type I Chemotype (THC-Dominant)

What Type I actually means

The chemotype system was proposed by Small and Beckstead in 1973 after they surveyed cannabinoid content across hundreds of cannabis accessions and found the plants sorted cleanly into groups based on the ratio of THC to CBD in mature flowers ^[1]. They defined three chemotypes:

• Type I: THC-dominant, low CBD (THC:CBD >> 1)
• Type II: roughly balanced THC and CBD
• Type III: CBD-dominant, low THC (hemp-type)

Later work added Type IV (CBG-dominant) and Type V (essentially cannabinoid-free fiber hemp) ^[2]. The system is based on chemistry, not on 'indica vs. sativa' morphology or on terpene profile. A short bushy plant and a tall lanky plant can both be Type I. Strong evidence

Note: this article was tagged internally as a 'terpene' entry, but Type I is a cannabinoid chemotype. We're keeping the tag but writing the article correctly.

The genetics behind it

In the plant, the direct precursor CBGA is converted to either THCA or CBDA by two closely related enzymes: THCA synthase and CBDA synthase. de Meijer and colleagues showed in 2003 that the THC:CBD ratio segregates in crosses as if controlled by a single locus with two codominant alleles, which they called B_T (THCA synthase) and B_D (CBDA synthase) ^[3]. A plant that is B_T/B_T produces almost entirely THCA — that's Type I. B_D/B_D gives Type III. Heterozygotes (B_T/B_D) give the roughly balanced Type II. Strong evidence

Later genomic work complicated this slightly — the THCAS and CBDAS genes sit in a complex, repeat-rich region and some 'Type I' plants actually carry nonfunctional CBDAS pseudogenes rather than a true alternative allele ^[4]. The practical prediction (B_T/B_T ≈ Type I) still holds up well in breeding.

Where Type I cannabis is found

Essentially all commercial 'marijuana' — the flower sold in adult-use and medical dispensaries in the US, Canada, the Netherlands, Germany, Thailand, and elsewhere — is Type I. Testing surveys of legal-market flower in Washington, Colorado, and California consistently show mean THC around 18–22% and CBD under 0.5% ^[5]. Illicit-market seizures analyzed by ElSohly's group at the University of Mississippi over four decades show a steady drift toward higher-THC Type I material and away from the more balanced profiles common in the 1970s and 80s ^[6]. Strong evidence

Type I plants are not tied to a single geography. Modern Type I cultivars descend from a global mix of landraces — Afghan hashish varieties, Mexican and Colombian sativas, Thai stick, South African Durban — most of which were themselves Type I or Type II before decades of selection pushed the market toward pure Type I.

Effects: what Type I actually predicts

Knowing a flower is Type I tells you it will get you high. It does not reliably tell you how strong, how sedating, how anxious-making, or how therapeutic that high will be. Those depend on total THC dose, individual tolerance, terpene profile, set and setting, and route of administration.

Human controlled studies confirm the obvious: THC-dominant cannabis produces intoxication, impaired short-term memory, altered time perception, increased heart rate, and — at higher doses — anxiety and psychotomimetic effects in some users ^[7]. Compared to Type II (balanced) flower, Type I is more likely to produce anxiety and paranoia at equivalent THC doses, and CBD appears to blunt some THC-induced effects, though the magnitude of that interaction is debated ^[8]. [evidence:strong for THC effects; evidence:disputed for the size of CBD's protective effect]

Medically, Type I flower and its extracts are used for chronic pain, chemotherapy-induced nausea, appetite stimulation, and spasticity. Evidence quality varies by indication — strongest for chemotherapy nausea and MS-related spasticity, weaker for chronic pain and sleep ^[9]. [evidence:strong to weak, depending on indication]

Strains and cultivars that are Type I

Rather than list strains — nearly every named cultivar you've heard of is Type I — it's more useful to list the exceptions. Type II (balanced) cultivars include Cannatonic, Harlequin, and Pennywise. Type III (CBD-dominant) cultivars include Charlotte's Web, ACDC, and Ringo's Gift. Type IV (CBG-dominant) examples include certain Bediol and Italian medical genetics.

Everything else in a typical dispensary case — OG Kush, Gorilla Glue #4, Blue Dream, Girl Scout Cookies, Wedding Cake, Runtz, Zkittlez, Sour Diesel, Northern Lights — is Type I. Strong evidence

A useful sanity check: if a lab COA shows THC around 15–30% and CBD under 1%, you have Type I flower, regardless of what marketing category (indica/sativa/hybrid) it's sold under.

Related classifications

• Type II Chemotype: roughly 1:1 to 2:1 THC:CBD. Heterozygous at the B locus.
• Type III Chemotype: CBD-dominant. Includes industrial hemp and CBD-medical cultivars.
• Type IV Chemotype: CBG-dominant. Rare; requires a defect downstream of CBGA.
• Type V Chemotype: essentially zero cannabinoids. Fiber hemp phenotype.

Chemotype is orthogonal to the indica vs. sativa marketing binary and to the plant's terpene profile. A Type I plant can be myrcene-dominant, limonene-dominant, terpinolene-dominant, or caryophyllene-dominant.

Sources

How this page was made